🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 755.72 -1.8% NASDAQ 100: 690.49 -3.5% Dow Jones: 534.08 -0.5%

Mraz Amerine & Associates - Q3 2026 13F Filings

MR

Mraz, Amerine & Associates, Inc.

CIK: 0001542324
Address: California Modesto 1120 13Th Street, Ste C
$640.23 M
Portfolio Value
198
Assets Held
Reporting Period: Q3 2026
Filing Status:
Active
Last Updated: 10/30/2026

Portfolio Summary (Q3 2026)

View Full Portfolio Analysis

Top Buys

Q3 2026
1. AVES Avantis Emerging Markets Value Etf
+$2.31 M
2. BN Brookfield Corporation
+$1.83 M
3. EWZS Ishares Msci Brazil Small-Cap Etf
+$1.15 M
4. MKL Markel Group
+$982,946.31
5. TFLO Ishares Treasury Floating Rate Bond Etf
+$571,050.96

Top Sells

Q3 2026
1. FRFHF Fairfax Financial Holdings Limited
−$48.46 M
2. Korea Fund
−$1.99 M
3. AVEM Avantis Emerging Markets Equity Etf
−$1.83 M
4. BRK.B Berkshire Hathaway
−$1.27 M
5. USFR Wisdomtree Floating Rate Treasury Fund
−$1.25 M

Asset Allocation

Stocks/ETFs
-8.15%
$638.72 M 99.76%
Options
$0 0.00%
Debt
$0 0.00%
Other
+2.85%
$1.51 M 0.24%

Sector Allocation (Stocks)

Mraz Amerine & Associates Q3 2026 Filing Summary

Mraz, Amerine & Associates, Inc. filed its 13F report for Q3 2026 on October 30, 2026. The portfolio totaled 640.23 M reflecting a -8.16% change from the prior quarter, spanning 198 assets. The top 10 holdings comprised 54.7% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 12 new positions and 12 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Mraz Amerine & Associates’s Q3 2026 Filing

Mraz Amerine & Associates submitted their Form 13F-HR for the Q3 2026 period on 10/30/2026. This was the only submission for the quarter.

In the Q3 2026 filing, Mraz Amerine & Associates reported a managed portfolio value of 640.23 M, consisting of 198 individual positions.

This page displays the raw filing documents. To see which stocks Mraz Amerine & Associates bought or sold during Q3 2026, please visit Mraz Amerine & Associates's Portfolio Analysis page.